Somerville, MA, United States of America

Nicholas Robert Perl

This inventor holds 19 USPTO granted patents and 18 published patent applications, plus 6 CIPO patents and 13 EPO patents, primarily in CNS Disease Treatment. Top assignees: Ironwood Pharmaceuticals, Inc., Cyclerion Therapeutics, Inc., Ribon Therapeutics, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas Robert Perl. Retrieved from https://idiyas.com/inventor/nicholas-robert-perl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 18)

% Patents Active = 89.5

CIPO Patents = 6 (Patent Applications = 8)

EPO Patents = 13 (Patent Applications = 14)

Average Co-Inventor Count = 7.1

ph-index = 7

Forward Citations = 110(Granted Patents)

Location History:

New York, NY (US) (2012 - 2014)
Brookline, MA (US) (2014 - 2016)
Cambridge, MA (US) (2022)
Somerville, MA (US) (2016 - 2023)

Company Filing History:

9 out of 44

Ironwood Pharmaceuticals, Inc.

patents

5 out of 25

Cyclerion Therapeutics, Inc.

patents

3 out of 12

Ribon Therapeutics, Inc.

patents

4. 2 out of 519

Sloan-Kettering Institute for Cancer Research

patents

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

PARP7 Inhibitors

CNS Diseases

sGC Stimulators

Heterobicyclic Amides

Triterpene Saponins

Pyrazoles

Methods of Synthesis

Therapeutics

Pharmaceuticals

Drug Development

Inhibitors

Biological Activity

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617782 - Pyridazinones as PARP7 inhibitors (2026-05-05),

2. 11691969 - Pyridazinones as PARP7 inhibtors (2023-07-04),

3. 11690828 - Treatment of CNS diseases with sGC stimulators (2023-07-04),

4. 11535621 - Heterobicyclic amides as inhibitors of CD38 (2022-12-27),

5. 11207323 - sGC stimulators (2021-12-28),

6. 10844064 - sGC stimulators (2020-11-24),

7. 10639308 - sGC stimulators (2020-05-05),

8. 10517874 - sGC stimulators (2019-12-31),

9. 10189809 - SGC stimulators (2019-01-29),

10. 10183021 - sGC stimulators (2019-01-22),

11. 10047095 - sGC stimulators (2018-08-14),

12. 9586937 - sGC stimulators (2017-03-07),

13. 9487508 - SGC stimulators (2016-11-08),

14. 9481689 - sGC stimulators (2016-11-01),

15. 9139564 - 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators (2015-09-22),

Title: The Innovative Journey of Nicholas Robert Perl

Introduction: Nicholas Robert Perl is a distinguished inventor based in Somerville, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Nicholas Robert Perl holds several patents in the areas of technology, healthcare, and consumer products, showcasing his versatility and creativity.

Career Highlights: With a career spanning over two decades, Nicholas Robert Perl has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have impacted industries worldwide.

Collaborations: Throughout his career, Nicholas Robert Perl has collaborated with leading companies, research institutions, and universities, fostering a culture of innovation and knowledge sharing.

Conclusion: Nicholas Robert Perl's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.